Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy PlanningShevanthi Nayagam, Timothy B. Hallett, Jidong Jia et al.|Clinical Infectious Diseases|2020Cited by 42
Investment Case for a Comprehensive Package of Interventions against Hepatitis B in ChinaShevanthi Nayagam, Timothy B. Hallett, Polin Chan et al.|Journal of Hepatology|2016Cited by 10
Cost estimate and budget impact analysis of implementing the new guidelines for management of hepatitis C virus in China: a micro-costing studyPolin Chan, Esther H. Chang, Kun Zhao et al.|The Lancet|2017Cited by 1